Low Serum Albumin Levels and B-Cell Subtypes Identified as Prognostic Factors in Elderly LBCL Patients

Researchers have identified two key prognostic factors for elderly patients diagnosed with large B-cell lymphoma (LBCL), according to a recent study. The findings highlight the significance of low serum albumin levels and specific B-cell subtypes, as determined by the Hans algorithm, in predicting patient outcomes. These factors may provide valuable insights into tailoring treatment strategies for individuals with this type of lymphoma.

The study emphasizes the role of serum albumin, a protein commonly used as an indicator of overall health, in assessing prognosis for LBCL patients. Low levels of this protein were associated with poorer outcomes. Additionally, researchers utilized the Hans algorithm—a method that classifies LBCL into subtypes based on cell origin—to further refine predictions about disease progression and response to treatment. By combining these two factors, the study offers a more detailed understanding of how biological markers can influence treatment approaches and outcomes in elderly patients with LBCL.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: January 25, 2026

Author

GOAI